
|Articles|February 1, 2003
Power adjustment at slit lamp: Pseudophakic light-adjustable IOL set to enter clinical trials
Orlando-A new light-adjustable IOL (LAL) has been designed that will allow for noninvasive correction of residual refractive errors present after cataract surgery, said Daniel M. Schwartz, MD, during the refractive surgery subspecialty day meeting prior to the annual meeting of the American Academy of Ophthalmology. Researchers are ready to begin testing the LAL in clinical trials, he added.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Bayer acquires Perfuse Therapeutics, partners with Iambic to expand ophthalmology and AI capabilities
2
Memento Medicines launches with $93 million Series A to advance Tie2-activating bispecific for retinal disease
3
Obstructive sleep apnea and glaucoma: What a 12.5-million-patient data set reveals
4
Meta's AI glasses for veterans: Canto-Sims, OD on closing the access gap
5


























